{{chembox
| verifiedrevid = 437193087
| ImageFile=Guanoxabenz.png
| IUPACName=2-{[(2,6-dichlorophenyl)methylidene]amino}-1-hydroxyguanidine
| OtherNames=
|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = P9HIK5V7WK
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 7842543
| InChI = 1/C8H8Cl2N4O/c9-6-2-1-3-7(10)5(6)4-12-13-8(11)14-15/h1-4,15H,(H3,11,13,14)/b12-4+
| InChIKey = QKIQJNNDIWGVEH-UUILKARUBE
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 461343
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H8Cl2N4O/c9-6-2-1-3-7(10)5(6)4-12-13-8(11)14-15/h1-4,15H,(H3,11,13,14)/b12-4+
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QKIQJNNDIWGVEH-UUILKARUSA-N
| CASNo_Ref = {{cascite|correct|??}}
| CASNo=24047-25-4
| PubChem=9567831
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04398
| SMILES = Clc1cccc(Cl)c1\C=N\N=C(/N)NO
| MeSHName=Guanoxabenz
  }}
|Section2={{Chembox Properties
| Formula=C<sub>8</sub>H<sub>8</sub>Cl<sub>2</sub>N<sub>4</sub>O
| MolarMass=247.08 g/mol
| Appearance=
| Density=
| MeltingPt=
| BoilingPt=
| Solubility=
  }}
|Section6={{Chembox Pharmacology
| ATCCode_prefix = C02
| ATCCode_suffix = CC07
}}
|Section7={{Chembox Hazards
| MainHazards=
| FlashPt=
| AutoignitionPt =
  }}
}}

'''Guanoxabenz''' is a metabolite of [[guanabenz]].<ref>{{Cite journal 
| last1 = Clement | first1 = B. 
| last2 = Demesmaeker | first2 = M. 
| title = Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2 
| journal = Drug metabolism and disposition: the biological fate of chemicals 
| volume = 25 
| issue = 11 
| pages = 1266â€“1271 
| year = 1997 
| pmid = 9351903
| url = http://dmd.aspetjournals.org/content/25/11/1266.long
}}</ref>

==References==
{{reflist}}

{{Adrenergic agonists}}

[[Category:Guanidines]]
[[Category:Alpha-adrenergic agonists]]
[[Category:Chloroarenes]]


{{antihypertensive-stub}}